Moreover, we found no significant contributions from the IGF2-H19, ZAC, PEG1, or PEG3 locus on the IR (Fig. 3a) or OS (Fig. 3b) of AML patients. This evidence concerns the gene IGF2 and acute myeloid leukemia.